4.7 Review

The Mitochondrial Response to DNA Damage

期刊

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2021.669379

关键词

mitochondrial DNA; DNA repair; mitochondrial fusion; mitochondrial fission; mitophagy

资金

  1. National Natural Science Foundation of China (NSFC) [82073257]
  2. University Natural Science Research Project of Anhui Province (China) [KJ2020A0159]

向作者/读者索取更多资源

Mitochondria are essential organelles in eukaryotic cells that provide energy through oxidative phosphorylation. Mitochondrial DNA is prone to damage by DNA damaging agents, which can lead to dysfunction and contribute to various human diseases. Understanding mtDNA repair mechanisms is crucial for developing therapeutic strategies.
Mitochondria are double membrane organelles in eukaryotic cells that provide energy by generating adenosine triphosphate (ATP) through oxidative phosphorylation. They are crucial to many aspects of cellular metabolism. Mitochondria contain their own DNA that encodes for essential proteins involved in the execution of normal mitochondrial functions. Compared with nuclear DNA, the mitochondrial DNA (mtDNA) is more prone to be affected by DNA damaging agents, and accumulated DNA damages may cause mitochondrial dysfunction and drive the pathogenesis of a variety of human diseases, including neurodegenerative disorders and cancer. Therefore, understanding better how mtDNA damages are repaired will facilitate developing therapeutic strategies. In this review, we focus on our current understanding of the mtDNA repair system. We also discuss other mitochondrial events promoted by excessive DNA damages and inefficient DNA repair, such as mitochondrial fusion, fission, and mitophagy, which serve as quality control events for clearing damaged mtDNA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biotechnology & Applied Microbiology

Roles of NOTCH1 as a Therapeutic Target and a Biomarker for Lung Cancer: Controversies and Perspectives

Lixia Guo, Ting Zhang, Ying Xiong, Yanan Yang

DISEASE MARKERS (2015)

Article Biochemistry & Molecular Biology

MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation

Lixia Guo, Jingyu Wang, Ping Yang, Qiang Lu, Ting Zhang, Yanan Yang

IUBMB LIFE (2015)

Article Multidisciplinary Sciences

A genetic cell context-dependent role for ZEB1 in lung cancer

Ting Zhang, Lixia Guo, Chad J. Creighton, Qiang Lu, Don L. Gibbons, Eunhee S. Yi, Bo Deng, Julian R. Molina, Zhifu Sun, Ping Yang, Yanan Yang

NATURE COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness

F. Yan, N. Shen, J. Pang, N. Zhao, B. Deng, B. Li, Y. Yang, P. Yang, J. R. Molina, S. Liu

ONCOGENE (2017)

Article Biochemistry & Molecular Biology

Macroautophagy Regulates Nuclear NOTCH1 Activity Through Multiple p62 Binding Sites

Ting Zhang, Lixia Guo, Yuanyuan Wang, Yanan Yang

IUBMB LIFE (2018)

Article Multidisciplinary Sciences

Lysyl hydroxylases are transcription targets for GATA3 driving lung cancer cell metastasis

Wei Liu, Ting Zhang, Lixia Guo, Yuanyuan Wang, Yanan Yang

SCIENTIFIC REPORTS (2018)

Article Biochemistry & Molecular Biology

Stromal extracellular matrix is a microenvironmental cue promoting resistance to EGFR tyrosine kinase inhibitors in lung cancer cells

Yuanyuan Wang, Ting Zhang, Lixia Guo, Tao Ren, Yanan Yang

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Nuclear TAZ activity distinctly associates with subtypes of non-small cell lung cancer

Yuanyuan Wang, Yang Han, Zhongliang Guo, Yanan Yang, Tao Ren

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Cell Biology

ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism

David H. Peng, Samrat T. Kundu, Jared J. Fradette, Lixia Diao, Pan Tong, Lauren A. Byers, Jing Wang, Jaime Rodriguez Canales, Pamela A. Villalobos, Barbara Mino, Yanan Yang, Rosalba Minelli, Michael D. Peoples, Christopher A. Bristow, Timothy P. Heffernan, Alessandro Carugo, Ignacio I. Wistuba, Don L. Gibbons

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Oncology

Germline Predisposition and Copy Number Alteration in Pre-stage Lung Adenocarcinomas Presenting as Ground-Glass Nodules

Yijiu Ren, Shujun Huang, Chenyang Dai, Dong Xie, Larry Zheng, Huikang Xie, Hui Zheng, Yunlang She, Fangyu Zhou, Yue Wang, Pengpeng Li, Ke Fei, Gening Jiang, Yang Zhang, Bo Su, E. Alejandro Sweet-Cordero, Nhan Le Tran, Yanan Yang, Jai N. Patei, Christian Rolfo, Gaetano Rocco, Andres Felipe Cardona, Alessandro Tuzi, Matteo B. Suter, Ping Yang, Wayne Xu, Chang Chen

FRONTIERS IN ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

Exendin-4 may improve type 2 diabetes by modulating the epigenetic modifications of pancreatic histone H3 in STZ-induced diabetic C57BL/6 J mice

Peipei Tu, Bin Huang, Minggang Li, Yaofang Zhang, Shixiang Bao, Na Tu, Yanan Yang, Jingtao Lu

Summary: Type 2 diabetes (T2D) is a complex systemic disease that might benefit from treatment with exendin-4, as shown in this study on C57BL/6 J mice. The study investigated epigenetic alterations in pancreatic tissues of diabetic mice and demonstrated an improvement in T2D progression with exendin-4 treatment through modulation of histone acetylation and methylation patterns. Understanding these epigenetic changes may lead to novel therapeutic approaches for T2D.

JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2022)

Review Immunology

A diversified role for γδT cells in vector-borne diseases

Chen Chen, Aibao Chen, Yanan Yang

Summary: Vector-borne diseases pose major health threats globally, and γδT cells play a crucial role in regulating host-pathogen interactions and disease progression.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer

Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi, Dongmei Lin

Summary: This study systematically investigated the pre-screening methods and characterized the genetic and clinical features of Lynch syndrome (LS) colorectal cancers (CRCs) in Asia. The results demonstrated that MMR IHC and MSI testing were effective methods for LS pre-screening and identified previously unreported pathogenic germline variants of MMR genes in LS patients.

CANCER BIOLOGY & MEDICINE (2022)

Article Oncology

Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation

Yung-Hung Luo, Han Liu, Jason A. Wampfler, Henry D. Tazelaar, Yalun Li, Tobias Peikert, Dan Liu, Konstantinos Leventakos, Yuh-Min Chen, Yanan Yang, Shih-Hwa Chiou, Ping Yang

Summary: This study demonstrates that osimertinib as a second or subsequent line of treatment in patients previously treated with EGFR-TKIs without identification of T790M mutation showed a lower risk of death compared to those who received first-line or second-generation TKIs without subsequent osimertinib. Patients with EGFR mutations and PD-L1 expression >= 50% had a higher risk of treatment failure with osimertinib and worse overall survival. These results suggest that osimertinib as a second-line or subsequent treatment may be a potential alternative for patients without identification of T790M, while high PD-L1 expression is associated with poor outcomes in patients receiving osimertinib.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)

暂无数据